NeurologyCardiovascularNephrologyInjection MoldingBiomedical EngineeringSurgeryHardwareHealth Care
Description
LeMaitre Vascular, Inc. (‘the company’) provides medical devices and human tissue cryopreservation services, which are largely used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company deve…
Analysis
Hope premium
LeMaitre Vascular, Inc. carries what we call a hope premium: an average business trading at an ambitious price. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is expensive. You pay 32.5× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 13% yearly growth; analysts expect 20%. The price, in other words, assumes less than the experts do.
The trajectory is solid and the balance sheet is adequate. The company scores 20/20 on our value-creation score: strong value creator.
What to watch: Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 2023100
82
2023202420252026
All-time high
100
Jan 2023
All-time low
63
Jan 2024
Average rank
86
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
22
7
19
45
Price/Earnings
19
10
20
48
Price/Book
27
27
41
44
Dividend Yield
93
92
94
96
Value (overall)
50
37
51
83
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.